SEC Form 5 · accession 0001209191-17-031052
VivoSim Labs, INC. · VIVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sharon Collins Presnell
Officer — Chief Scientific Officer
Period of report
Mar 31, 2017
Accepted (ET)
May 9, 2017 · 6:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001497253
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Mar 18, 2017 | G | 15,000 | $0.00 | D | 100,355 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction represents charitable contributions by the Reporting Person.
- F2This number does not include 1,282,192 shares of common stock underlying outstanding options held by Dr. Presnell; post-transaction Dr. Presnell continues to beneficially own or have a right to acquire 1,382,547 shares of common stock.